Meetings of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 79893-79894 [2022-28217]

Download as PDF ddrumheller on DSK6VXHR33PROD with NOTICES Federal Register / Vol. 87, No. 248 / Wednesday, December 28, 2022 / Notices Court of Federal Claims No: 22–1627V 2. Daniel Lenehan, Bethel Park, Pennsylvania, Court of Federal Claims No: 22–1629V 3. Marc Wushowunan Livingston, San Diego, California, Court of Federal Claims No: 22–1630V 4. Amy Watkins, Bangor, Maine, Court of Federal Claims No: 22–1632V 5. Mandi J. Bravo, Caldwell, Idaho, Court of Federal Claims No: 22–1633V 6. Barbara Fribush, Boston, Massachusetts, Court of Federal Claims No: 22–1635V 7. Emily Barmichael on behalf of E. C. B., Hollywood, Florida, Court of Federal Claims No: 22–1636V 8. Elisabeth Kelley, Hixson, Tennessee, Court of Federal Claims No: 22–1639V 9. Stephanie Harlow, Little Compton, Rhode Island, Court of Federal Claims No: 22– 1640V 10. Stephanie Smith, Wenonah, New Jersey, Court of Federal Claims No: 22–1641V 11. Amy Corneli, Durham, North Carolina, Court of Federal Claims No: 22–1642V 12. Lakeevra Butler, Conyers, Georgia, Court of Federal Claims No: 22–1644V 13. Cherlyn Jensen, Kapolei, Hawaii, Court of Federal Claims No: 22–1645V 14. Sage Comora, Pueblo, Colorado, Court of Federal Claims No: 22–1646V 15. Trudee Ann Mendonca, Riverside, Rhode Island, Court of Federal Claims No: 22– 1647V 16. Tamika Boatwright, Ellicott City, Maryland, Court of Federal Claims No: 22–1648V 17. Lynne Guzman on behalf of S. F., Deceased, Phoenix, Arizona, Court of Federal Claims No: 22–1649V 18. Israel Collins, Portland, Maine, Court of Federal Claims No: 22–1650V 19. Catherine Carone on behalf of N. C., Park Ridge, Illinois, Court of Federal Claims No: 22–1651V 20. Miriam Moody, New Bern, North Carolina, Court of Federal Claims No: 22–1652V 21. Allison Roosa, Philadelphia, Pennsylvania, Court of Federal Claims No: 22–1653V 22. Amanda Gray, Charlottesville, Virginia, Court of Federal Claims No: 22–1654V 23. Deana Lasseter, Marietta, Georgia, Court of Federal Claims No: 22–1655V 24. Shea Gillstrap on behalf of A. N., Phoenix, Arizona, Court of Federal Claims No: 22–1658V 25. Lucille Abshire, Inwood, West Virginia, Court of Federal Claims No: 22–1659V 26. Thomas M. Murray and Maria Murray on behalf of M. M., Phoenix, Arizona, Court of Federal Claims No: 22–1660V 27. Erika Franks, Phoenix, Arizona, Court of Federal Claims No: 22–1661V 28. Dajuan Williams, Boscobel, Wisconsin, Court of Federal Claims No: 22–1662V 29. Setsu Korb, San Juan Capistrano, California, Court of Federal Claims No: 22–1665V 30. Kristin Thompson on behalf of K. T., Phoenix, Arizona, Court of Federal Claims No: 22–1667V 31. Mary Harnocz, Phoenix, Arizona, Court of Federal Claims No: 22–1668V 32. Angelina Diaz, Ennis, Texas, Court of VerDate Sep<11>2014 18:26 Dec 27, 2022 Jkt 259001 Federal Claims No: 22–1669V 33. Sue Cardona on behalf of T. C., Phoenix, Arizona, Court of Federal Claims No: 22– 1670V 34. Derek Workman, Maitland, Florida, Court of Federal Claims No: 22–1671V 35. Kathleen Collins, Livonia, Michigan, Court of Federal Claims No: 22–1672V 36. Alice Thierfelder, Marshfield, Wisconsin, Court of Federal Claims No: 22–1674V 37. Susann Frink, Rochester, New York, Court of Federal Claims No: 22–1675V 38. Rosanna Charles, San Jose, California, Court of Federal Claims No: 22–1678V 39. James Command on behalf of the estate of Kathleen Command, Deceased, Grand Rapids, Michigan, Court of Federal Claims No: 22–1679V 40. Vanvette Heath, Brooklyn, New York, Court of Federal Claims No: 22–1680V 41. Ada Mochari, Mineola, New York, Court of Federal Claims No: 22–1681V 42. Corine Jefferson, Akron, Ohio, Court of Federal Claims No: 22–1683V 43. James Dalrymple, Leland, North Carolina, Court of Federal Claims No: 22–1684V 44. Kathy Nicholas, Searcy, Arkansas, Court of Federal Claims No: 22–1685V 45. Georgia Jackson, Meridian, Mississippi, Court of Federal Claims No: 22–1686V 46. Tessa Lee-Thomas, Brooklyn, New York, Court of Federal Claims No: 22–1687V 47. Frances Kerr, Katy, Texas, Court of Federal Claims No: 22–1688V 48. Edwin Hauer, St. Cloud, Minnesota, Court of Federal Claims No: 22–1692V 49. Kimberly Mosley, Charlotte, North Carolina, Court of Federal Claims No: 22–1697V 50. Mary Capri, Lake Forest, Illinois, Court of Federal Claims No: 22–1698V 51. Tobey Nichols, Parkersburg, West Virginia, Court of Federal Claims No: 22– 1700V 52. Sicely D. Martin, Lee’s Summit, Missouri, Court of Federal Claims No: 22–1702V 53. Lloyd McKay, Houma, Louisiana, Court of Federal Claims No: 22–1703V 54. Megan Bortles, Englewood, Colorado, Court of Federal Claims No: 22–1704V 55. Kelly McClusky on behalf of L. M., Phoenix, Arizona, Court of Federal Claims No: 22–1706V 56. Sarah Grindle, Longmont, Colorado, Court of Federal Claims No: 22–1707V 57. Michael Barnes, Frankenmuth, Michigan, Court of Federal Claims No: 22–1708V 58. Robert Moore, San Jose, California, Court of Federal Claims No: 22–1712V 59. Susan Rogers, Grass Valley, California, Court of Federal Claims No: 22–1714V 60. Staci Metzger, Boston, Massachusetts, Court of Federal Claims No: 22–1715V 61. Ilene Robinson Sunshine, Boston, Massachusetts, Court of Federal Claims No: 22–1717V 62. Janet Wichman, Montrose, California, Court of Federal Claims No: 22–1718V 63. Deborah Butler, Boston, Massachusetts, Court of Federal Claims No: 22–1719V 64. James Winfield, Arthur, Illinois, Court of Federal Claims No: 22–1721V 65. Karl Wittmann, New York, New York, Court of Federal Claims No: 22–1722V 66. Lourdes Irizarry Santiago, Boston, Massachusetts, Court of Federal Claims PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 79893 No: 22–1723V 67. Hanna Battung, Commerce, California, Court of Federal Claims No: 22–1725V 68. Jenna Raimond, Phoenix, Arizona, Court of Federal Claims No: 22–1726V 69. Jessica Fischer, Phoenix, Arizona, Court of Federal Claims No: 22–1727V 70. Trella Adams, Perry, Georgia, Court of Federal Claims No: 22–1728V 71. Sharon H. Rambo, Midlothian, Texas, Court of Federal Claims No: 22–1731V 72. Daniel Goddard, New York, New York, Court of Federal Claims No: 22–1733V 73. Laurie Ryan, Colorado Springs, Colorado, Court of Federal Claims No: 22–1734V 74. Amy McAllister, Columbus, Ohio, Court of Federal Claims No: 22–1735V 75. Joyce Stegall, Flossmoor, Illinois, Court of Federal Claims No: 22–1737V 76. Juanita Fishbaugh, Spokane, Washington, Court of Federal Claims No: 22–1742V 77. Avia McDaniel, Cibolo, Texas, Court of Federal Claims No: 22–1743V 78. Tory Boyer, Wilmette, Illinois, Court of Federal Claims No: 22–1746V 79. John Buonocore, Washington, District of Columbia, Court of Federal Claims No: 22–1747V 80. Margaret Tremba, Greensburg, Pennsylvania, Court of Federal Claims No: 22–1749V 81. Isabella Domotor, Phoenix, Arizona, Court of Federal Claims No: 22–1750V 82. Kelly Wasko, Boston, Massachusetts, Court of Federal Claims No: 22–1751V 83. Laura Cymansky, Denver, Colorado, Court of Federal Claims No: 22–1752V [FR Doc. 2022–28224 Filed 12–27–22; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meetings of the Presidential Advisory Council on Combating AntibioticResistant Bacteria Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB). The meeting will be open to the public via Zoom and teleconference; a pre-registered public comment session will be held during the meeting. Pre-registration is required for members of the public who wish to present their comments at the meeting via Zoom/teleconference. Individuals who wish to send in their written public comment should send an email to CARB@hhs.gov. Registration information is available on the website SUMMARY: E:\FR\FM\28DEN1.SGM 28DEN1 ddrumheller on DSK6VXHR33PROD with NOTICES 79894 Federal Register / Vol. 87, No. 248 / Wednesday, December 28, 2022 / Notices https://www.hhs.gov/paccarb and must be completed by January 18, 2023 for the January 24–25, 2023 Public Meeting. Additional information about registering for the meeting and providing public comment can be obtained at https:// www.hhs.gov/paccarb on the Upcoming Meetings page. DATES: The meeting is scheduled to be held on January 24–25, 2023, from 10 a.m. to 4 p.m. ET (times are tentative and subject to change). The confirmed times and agenda items for the meeting will be posted on the website for the PACCARB at https://www.hhs.gov/ paccarb when this information becomes available. Pre-registration for attending the meeting is strongly suggested and should be completed no later than January 18, 2023. ADDRESSES: Instructions regarding attending this meeting virtually will be posted at least one week prior to the meeting at: https://www.hhs.gov/ paccarb. FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated Federal Officer, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, 1101 Wootton Parkway, Rockville, MD 20852. Phone: 202–746– 1512; Email: CARB@hhs.gov. SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB), established by Executive Order 13676, is continued by section 505 of Public Law 116–22, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAIA). Activities and duties of the Advisory Council are governed by the provisions of the Federal Advisory Committee Act (FACA), Public Law 92–463, as amended (5 U.S.C. app.), which sets forth standards for the formation and use of Federal advisory committees. The PACCARB shall advise and provide information and recommendations to the Secretary regarding programs and policies intended to reduce or combat antibioticresistant bacteria that may present a public health threat and improve capabilities to prevent, diagnose, mitigate, or treat such resistance. The PACCARB shall function solely for advisory purposes. Such advice, information, and recommendations may be related to improving: the effectiveness of antibiotics; research and advanced research on, and the development of, improved and innovative methods for VerDate Sep<11>2014 18:26 Dec 27, 2022 Jkt 259001 combating or reducing antibiotic resistance, including new treatments, rapid point-of-care diagnostics, alternatives to antibiotics, including alternatives to animal antibiotics, and antimicrobial stewardship activities; surveillance of antibiotic-resistant bacterial infections, including publicly available and up-to-date information on resistance to antibiotics; education for health care providers and the public with respect to up-to-date information on antibiotic resistance and ways to reduce or combat such resistance to antibiotics related to humans and animals; methods to prevent or reduce the transmission of antibiotic-resistant bacterial infections; including stewardship programs; and coordination with respect to international efforts in order to inform and advance the United States capabilities to combat antibiotic resistance. The January 24–25, 2023, public meeting will continue the PACCARB’s discussion about how antimicrobial resistance can be integrated into existing national pandemic preparedness plans. The focus of the meeting will be exploring the challenges regarding communicating science and antimicrobial resistance during a pandemic, as well as exploring how to address equity and vulnerable populations in these plans. The meeting agenda will be posted on the PACCARB website at https://www.hhs.gov/paccarb when it has been finalized. All agenda items are tentative and subject to change. Instructions regarding attending the meeting virtually will be posted at least one week prior to the meeting at: https://www.hhs.gov/paccarb. Members of the public will have the opportunity to provide comments live during the January meeting by preregistering online at https:// www.hhs.gov/paccarb. Pre-registration is required for participation in this session with limited spots available. Written public comments can also be emailed to CARB@hhs.gov by midnight January 18, 2023 and should be limited to no more than one page. All public comments received prior to January 18, 2022, will be provided to the PACCARB members. Additionally, companies and/ or organizations involved in combating antibiotic resistance have an opportunity to present their work to members of the PACCARB live during an Innovation Spotlight. Pre-registration is required for participation, with limited spots available. All information regarding this session can also be found online at https://www.hhs.gov/paccarb. PO 00000 Frm 00046 Fmt 4703 Sfmt 9990 Dated: November 22, 2022. Jomana F. Musmar, Designated Federal Officer, Presidential Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant Secretary for Health. [FR Doc. 2022–28217 Filed 12–27–22; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel Aging and cognitive decline. Date: January 3, 2023. Time: 11:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Joanna Szczepanik, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institute of Health, 6701 Rockledge Drive, Room 1000D, Bethesda, MD 20892, (301) 827–2242 szczepaj@csr.nih.gov This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS). Dated: December 21, 2022. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–28183 Filed 12–27–22; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\28DEN1.SGM 28DEN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 87, Number 248 (Wednesday, December 28, 2022)]
[Notices]
[Pages 79893-79894]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-28217]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meetings of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting is scheduled to be held for the Presidential Advisory 
Council on Combating Antibiotic-Resistant Bacteria (PACCARB). The 
meeting will be open to the public via Zoom and teleconference; a pre-
registered public comment session will be held during the meeting. Pre-
registration is required for members of the public who wish to present 
their comments at the meeting via Zoom/teleconference. Individuals who 
wish to send in their written public comment should send an email to 
[email protected]. Registration information is available on the website

[[Page 79894]]

https://www.hhs.gov/paccarb and must be completed by January 18, 2023 
for the January 24-25, 2023 Public Meeting. Additional information 
about registering for the meeting and providing public comment can be 
obtained at https://www.hhs.gov/paccarb on the Upcoming Meetings page.

DATES: The meeting is scheduled to be held on January 24-25, 2023, from 
10 a.m. to 4 p.m. ET (times are tentative and subject to change). The 
confirmed times and agenda items for the meeting will be posted on the 
website for the PACCARB at https://www.hhs.gov/paccarb when this 
information becomes available. Pre-registration for attending the 
meeting is strongly suggested and should be completed no later than 
January 18, 2023.

ADDRESSES: Instructions regarding attending this meeting virtually will 
be posted at least one week prior to the meeting at: https://www.hhs.gov/paccarb.

FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated 
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, 1101 Wootton Parkway, 
Rockville, MD 20852. Phone: 202-746-1512; Email: [email protected].

SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on 
Combating Antibiotic-Resistant Bacteria (PACCARB), established by 
Executive Order 13676, is continued by section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation 
Act of 2019 (PAHPAIA). Activities and duties of the Advisory Council 
are governed by the provisions of the Federal Advisory Committee Act 
(FACA), Public Law 92-463, as amended (5 U.S.C. app.), which sets forth 
standards for the formation and use of Federal advisory committees.
    The PACCARB shall advise and provide information and 
recommendations to the Secretary regarding programs and policies 
intended to reduce or combat antibiotic-resistant bacteria that may 
present a public health threat and improve capabilities to prevent, 
diagnose, mitigate, or treat such resistance. The PACCARB shall 
function solely for advisory purposes.
    Such advice, information, and recommendations may be related to 
improving: the effectiveness of antibiotics; research and advanced 
research on, and the development of, improved and innovative methods 
for combating or reducing antibiotic resistance, including new 
treatments, rapid point-of-care diagnostics, alternatives to 
antibiotics, including alternatives to animal antibiotics, and 
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health 
care providers and the public with respect to up-to-date information on 
antibiotic resistance and ways to reduce or combat such resistance to 
antibiotics related to humans and animals; methods to prevent or reduce 
the transmission of antibiotic-resistant bacterial infections; 
including stewardship programs; and coordination with respect to 
international efforts in order to inform and advance the United States 
capabilities to combat antibiotic resistance.
    The January 24-25, 2023, public meeting will continue the PACCARB's 
discussion about how antimicrobial resistance can be integrated into 
existing national pandemic preparedness plans. The focus of the meeting 
will be exploring the challenges regarding communicating science and 
antimicrobial resistance during a pandemic, as well as exploring how to 
address equity and vulnerable populations in these plans. The meeting 
agenda will be posted on the PACCARB website at https://www.hhs.gov/paccarb when it has been finalized. All agenda items are tentative and 
subject to change. Instructions regarding attending the meeting 
virtually will be posted at least one week prior to the meeting at: 
https://www.hhs.gov/paccarb.
    Members of the public will have the opportunity to provide comments 
live during the January meeting by pre-registering online at https://www.hhs.gov/paccarb. Pre-registration is required for participation in 
this session with limited spots available. Written public comments can 
also be emailed to [email protected] by midnight January 18, 2023 and should 
be limited to no more than one page. All public comments received prior 
to January 18, 2022, will be provided to the PACCARB members. 
Additionally, companies and/or organizations involved in combating 
antibiotic resistance have an opportunity to present their work to 
members of the PACCARB live during an Innovation Spotlight. Pre-
registration is required for participation, with limited spots 
available. All information regarding this session can also be found 
online at https://www.hhs.gov/paccarb.

    Dated: November 22, 2022.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for 
Health.
[FR Doc. 2022-28217 Filed 12-27-22; 8:45 am]
BILLING CODE 4150-44-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.